申请人:VM THERAPEUTICS LLC
公开号:WO2014143915A1
公开(公告)日:2014-09-18
The present invention relates to novel crystalline polymorphic forms of 3-(2-4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)-2-methyl-4H-pyrido[1,2-α]pyrimidin-4-one.The present invention also includes the methods of making crystalline polymorphic forms thereof and the use thereof for preparing a pharmaceutical composition.
本发明涉及一种新的晶态多形形式的3-(2-4-[(4-氟苯基)羰基]哌啶-1-基}乙基)-2-甲基-4H-吡啶[1,2-α]嘧啶-4-酮。本发明还包括制备晶态多形形式的方法以及用于制备药物组合物的使用方法。